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Introduction
Prostate cancer (PCa) is among the most prevalent cancers worldwide and is the third most common cause of cancer-associated mortality in men [1] . The recent worldwide PCa incidence of newly diagnosed cases has been estimated at 7.9% of all cancers [2] . Due to its' prevalence and the significant burden of diagnosis and treatment, research within PCa has always been a topical and high impact focus region within the contemporary medical literature.
Within medical literature, the number of citations that a published article achieves has been traditionally used to evaluate its intellectual impact it has on research within that topic or specific research focus. Despite the controversies associated with the Citation Index (CI) and the resulting Journal Impact Factor (IF), it is still a globally recognised parameter in the evaluation of academic research, or intellectual influence within any field [3] .
To provide us with an understanding of "prostate cancer" research associated focus areas, the first ever bibliometric analysis in this research topic is performed. Information of the areas of greatest citation potential, regions performing high impact research, centers and authors responsible, journal platforms utilised were thus ascertained. Further, an independent rank of all relevant publications, including a comprehensive literature-wide CI-rating was to be performed within the field of PCa.
Therefore, we aimed to perform the first comprehensive, comparative bibliometric analysis of the "Top 100 most cited articles in the field of PCa" (T100).
Materials and Methods

Search Strategy
To identify the most cited articles in the field of "prostate cancer", a comprehensive search was performed using the Web of Science Database (v.5.21) (January 1, 1945 to February 2, 2016 ; covering the Web of Science TM Core Collection, BIOSIS Previews, Central Contents connect, KCI-Korean Journal Database, MEDLINE, SciELO Citation Index, Russian Science Citation and the Chinese Science Citation Database. Search keywords utilized included: prostate/prostatic cancer, prostate/prostatic carcinoma, prostate/prostatic neoplasm/s, and prostate/prostatic adenocarcinoma.
Restriction was not performed to "urology and nephrology" journals only, since other journals may have highly cited research that may fall outside this journal sub-category, but may still be related to PCa research. No language restrictions were applied.
Citation and Publication Data
Following the comprehensive search strategy performed on Web of Science Databases, the resulting outcome was sorted by "Times cited -highest to lowest". The highest 100 ranked articles were recorded. Data including publication year, journal of publication, authors, affiliated institutions, country of origin and citation data were extracted for analysis.
"Publication year" was determined as per indexing on the Web of Science Database. Journal IF data was obtained from the Journal of Citation Reports [4] . The "primary author" was determined as the first author on the respective publication. In the case of coauthorship, the first listed author was determined as the primary author. "Country of origin" was based on the territory or country of the author affiliation as listed within the publication. "Affiliated institutions" were based on the institutions listed within the publication. In the setting of multi-institutional studies, each institution was counted individually. Ranking of respective institutions were based on the Shanghai Academic Ranking of World Universities (ARWU), Leiden and Quacquarelli Symonds (QS) World Ranking, as ranked on July 25, 2016 [5-7] .
Citation data was obtained as calculated by Web of Science Databases. To adjust for the "exposure time" of articles published prior to 2016, an Adjusted Citation Index (ACI), used in prior bibliometric analysis [8] , was also calculated, using the equation: ACI = Number of citations/(2016 Year of publication).
To adjust for the "expenditure" on research, the ranking was adjusted by percentage of gross domestic product (GDP) on research per country. GDP data was obtained from the World Bank data [9] . To perform this adjustment, the following equation from a previous publication [10], was utilized: Corrected score for percentage GDP on research = Citation record/percentage GDP on research.
Results
ACI
The T100 are listed in table 1. These articles were cited 582 to 3,387 times, with a median citation rate of 853. Articles featuring in the T100 were all published from 1966 to 2012.
Recalculation using the ACI resulted in a drastic change of the overall ranking, with the previously seventh ranked most cited paper [11] , ranking highest (table  1) . Further, the initially ranked sixty-ninth paper [12] , after applying the ACI, was ranked last of the T100 at 100.
Journals
General medical or oncology journals dominated the top positions within this category (table 2). The New England Journal of Medicine had published most of the T100 publications (n = 21). It also had the highest IF from the list of Journals assessed. Among the "nephrology and urology" journal category, The Journal of Urology had the most publications (n = 5), followed by European Urology (n = 2).
Country of Origin versus GDP% on Research, Adjusted Score, and Adjusted Rank
When reviewing the geographic origin of the T100, contributions from USA (n = 86), Canada (n = 16) and United Kingdom (n = 15) were most prominent. The corresponding record count is tabulated in table 3 (countries where 2 or more papers of the T100 originated), and the corresponding figure 1.
In ranking various countries research output, the correcting formula for percentage spent on GDP was utilised [10] . Despite this adjustment, USA still featured most prominently in the T100.
Article Category and Type
A further breakdown of the T100, into the research associated categories based on the "Main content" category and the listed "Web of Science category" was asCurr Urol 2017;11: [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] Top 100 Cited Articles in Prostate Cancer 27
Adam/Ras/Bhattu/Raman/Perera sessed. Of these categories; genetics and biomarkers (n = 34), management of PCa (n = 25), physiology/biology/ pathophysiology (n = 11) and content related to classification/grading/staging/nomograms (n = 11) were most prominent ( fig. 2) . If the prepopulated "Web of Science" category within the T100 is further analysed, then PCa research ranked under medicine general internal (n = 36), oncology (n = 31), multidisciplinary sciences (n = 12), urology nephrology (n = 9) is most featured (fig. 3 ). Of the T100 articles, article types included original articles (n = 93), reviews (n = 4), notes (n = 2) and proceedings paper (n = 1).
Performance within T100 over Allocating number of articles within 5 year intervals from 1990, revealed the most "intellectually productive" time frame being from 1995 to 1999. With the most prolific year being the year 2005, when 8 papers within the T100 were published within that year (fig. 4) .
Center of Origin (University or Center) versus International Rank (ARWU, QS, Leidin Ranking System)
Research centers or universities with at least 5 papers within the T100 were tabulated (table 4). Harvard University was the institution that had the most T100 contributions (n = 20) within this review. The center responsible for the most T100, was observed to be within the top 2 of all the University rankings assessed.
Centers or universities with at least 5 citations within the T100 have been listed. Three research centers (non -university centers) were also observed within this list; National Cancer Institute, Memorial Sloan Kettering Cancer Center and the Brigham and Women's Hospital. Authorship (Total, First, Co-Author) Authors with at least 4 publications within the T100 were tabulated (table 5). The author Catalona W. J., is responsible for the most (n = 4) T100 articles as a first author in the observed history of PCa research. The authors Crawford E. D. and Walsh P. C., have both contributed to the most (n = 7) T100 articles as author and co-author combined. The list of the top ranked author list within T100 (number of publications listed as first and co-author) is tabulated (table 6). The top ranked combined first and co-author was Crawford E. D. and Walsh P. C. with 7 cumulative publications within the T100. Adam/Ras/Bhattu/Raman/Perera
Languages of Publication
All papers included within the T100, were published in the English language.
Discussion
PCa represents a rapidly evolving field and accounts for a considerable proportion of urological publications within the contemporary medical literature. To better understand this dynamic research focus area, we performed a comparative bibliometric analysis in PCa research. The findings of the current study demonstrate that North American and European institutions dominate the T100 PCa publications. Further, our findings demonstrate that articles pertaining to PCa genetics and biomarkers represent the highest citation potential.
Within medical literature, there is an absence of a universally-accepted absolute bibliometric comparator [13] . As such, CI may represent a useful objective measure of intellectual influence to a particular field. Previous citation bibliometric analyses have been reported in the fields of psoriasis [14] , pediatric neuro-surgery [8], spine-related research [15] , cardiovascular research [16] , dentistry [17] , and within adult and pediatric urology [18] [19] [20] [21] . These bibliometric evaluations provided a clearer "snapshot" of articles and associated research focus areas which have generated the most "intellectual influence" within the particular research focus area analysed. Despite this, there are inherent limitations in using citation data as a marker of intellectual influence that should be noted. A recent review observed that the CI alone was also not a good marker when reviewing the prescribed or suggested reading or study material when Fig. 2 . Actual "content-related" categories associated with PCa. Fig. 3 . Web of Science associated categories associated with PCa.
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preparing for the Fellow of the Royal College of Surgeons Urology Examination [22] . Furthermore, certain strategies are well known to increase the CI. These include using consistent name and affiliations, publishing in high IF journals, using an international collaborative authorship approach or publishing across fields [23] . Our study highlights the predominance of publications originating from institutions located in USA or Europe. Specifically, of the affiliated countries, USA accounted for the largest total (86/203). Further, we identified that medical and oncological journals represented a significant proportion of publications within in the T100, while The Journal of Urology was the highest ranked journal in the "urology and nephrology" category. Our results have corroborated with a previous bibliometric review of the T100 cited articles in "general" urology [19] . Nason et al. [19] observed a majority of the articles originated from USA (77/100), most in the field of oncology (54/100). Further, this group identified that The Journal of Urology published these articles most frequently (16/100) within the journals within the "urology and nephrology" category. These sentiments were further echoed by an earlier review of 1,239 "citation classics" [20] , in urology, where a "citation classic" was defined as a paper with a CI of more than 100. In their review, the articles originated from USA accounted for the majority (774/1,239) of papers assessed. Similar to Nason et al.
[19] the category of "prostate cancer and PSA" was the most prevalent (33.5%) category. Furthermore, amongst the journals assessed, The Journal of Urology had listed the most cites within the "urology and nephrology" category. Controversy exists in the geographical region of distribution of the T100 and the fact that the preferential citation biases from the USA, by other American authors and may lead to an over-estimated CI [10] .
An attempt at adjusting for PCa research per country by factoring the percentage of GDP given for research was also explored in this study, and this change is reflected in table 3. Despite adjusting for this variable within our study, the USA is still top ranked. This finding had been previously observed in a review of the "geographical origin" of publications within the urological literature, where adjusting the ranking using the percentage spent on research per GDP, did have an impact on the overall rank [10] . This may be explained by the previously noted "preferential citation biases" from the USA, by other American authors, which in turn may lead to an over-estimated CI [10] .
Certain content relevant to PCa research may be highly citable and may not be contained in the "urology and nephrology" journal category, so we opted not to include a limitation to the journal category searched. This Adam/Ras/Bhattu/Raman/Perera allowance proved to be significant, since the top ranked article in the T100 [24] , was published in a category outside the "urology and nephrology" journal category.
There are several limitations to the current study. Firstly, as previously discussed, there are inherent limitations in using citation data in bibliometric analyses. Secondly, our study utilized only the Web of Science Database. A number of alternate databases that calculate citation metrics are available including Google Scholar, Science Direct and EMBASE. The Web of Science was selected as it includes "older" publications, although the Scopus database is more extensive in more recent literature records. Nevertheless, Web of Science database was utilized as the duration of publication has a greater impact on citation [25] . Thirdly, this study did not review actual book chapters or book content, and unpublished Ph.D. and masters dissertations were also not assessed. These were excluded in the search term as the book databases are less encompassing and thus citation records would prove challenging to review.
Furthermore, there may well be research content that may have had an influence but has not been cited or not cited correctly. Also, publication bias or un-blinded peer-review, may also play a role in the publication process, where more prominent authors or institutions have preference over others. Further, the citation score may not always reflect the inherent quality of a particular finding, research paper. The topic of "prostate cancer" is indeed a multifaceted, so isolating a certain subset within this field may have been more accurate in the assessment process. Self or over citation of author's publications may also weigh heavily on the CI, sometimes without appropriate merit. Finally, a hallmark paper by Huggins and Hodges (1941) [26] , was excluded due to our study search date limitation . Their article was the first translational research study in hormonal therapy and PCa and earned the first author Charles Brenton Huggins, a Nobel prize in the category of physiology or medicine in the year 1966 [27] . A citation search on the Web of Science performed for their article returned 2,578 citations, which would have placed this third on the overall CI ranking in the T100.
In conclusion, despite the controversies involved in the CI of published research, it has remained a recording measure of academic, peer-reviewed research. We present the first comparative, bibliometric study to review the CI and citation metrics in the field of PCa research. Geographic regions that pre-dominate the literature amongst the T100 include North America and Europe. Publications originating from higher IF journals, English language medium of publication, original article format and multi-center collaborative research was observed to be more prominent amongst the T100. Areas within PCa research that are related to the content category of genetics and biomarkers have the highest citation potential. Amongst the journal category "urology and nephrology", most T100 were published in The Journal of Urology. When assessing within all journal categories, The New England Journal of Medicine leads the list. All these above mentioned factors may have an implication on future citation potential in PCa research, the funding and choice of associated research focus that academic urologists take in the future.
